IDEXX Laboratories, Inc. beat EPS estimates 94% of the time across 16 reported quarters (15 beats, 1 misses), averaging +5.2% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $3.95 | $4.27 | +8.1% | Beat | |
| Q1 FY26 | $3.42 | $3.47 | +1.5% | Beat | |
| Q4 FY25 | $2.93 | $3.08 | +5.1% | Beat | Q4 FY25 call · transcript |
| Q3 FY25 | $3.14 | $3.40 | +8.3% | Beat | |
| Q2 FY25 | $3.31 | $3.63 | +9.7% | Beat | Q2 FY25 call · transcript |
| Q1 FY25 | $2.92 | $2.96 | +1.4% | Beat | |
| Q4 FY24 | $2.40 | $2.62 | +9.2% | Beat | |
| Q3 FY24 | $2.69 | $2.80 | +4.1% | Beat | |
| Q2 FY24 | $2.87 | $2.44 | -15.0% | Miss | |
| Q1 FY24 | $2.68 | $2.81 | +4.8% | Beat | |
| Q4 FY23 | $2.12 | $2.32 | +9.4% | Beat | |
| Q3 FY23 | $2.37 | $2.53 | +6.8% | Beat |
Back to IDXX overview · IDXX holders · IDXX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.